166525-97-9 Usage
Uses
Used in Pharmaceutical Industry:
1-(4-Bromo-2-chlorophenyl)propan-1-one is used as an intermediate in the production of pharmaceuticals for its ability to be incorporated into various drug molecules, contributing to the development of new medications.
Used in Organic Compounds Production:
1-(4-Bromo-2-chlorophenyl)propan-1-one is used as an intermediate in the synthesis of other organic compounds, enabling the creation of a wide range of chemical products.
Used in Research and Development:
1-(4-Bromo-2-chlorophenyl)propan-1-one is utilized in research and development for its potential applications in the discovery and understanding of new chemical reactions and processes, furthering the knowledge in organic chemistry.
Used in Chemicals and Materials Production:
1-(4-Bromo-2-chlorophenyl)propan-1-one is employed in the production of other chemicals and materials, making it a versatile compound with various applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 166525-97-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,6,5,2 and 5 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 166525-97:
(8*1)+(7*6)+(6*6)+(5*5)+(4*2)+(3*5)+(2*9)+(1*7)=159
159 % 10 = 9
So 166525-97-9 is a valid CAS Registry Number.
166525-97-9Relevant academic research and scientific papers
INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME
-
Page 67, (2008/06/13)
The invention relates to compounds of the formula (I) and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula (I), and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula (I). The invention also relates to methods of preparing the compounds of formula (I).
Benzyl vinylogous amide substituted aryldihydropyridazinones and aryldimethylpyrazolones as potent and selective PDE3B inhibitors
Edmondson, Scott D.,Mastracchio, Anthony,He, Jiafang,Chung, Christine C.,Forrest, Michael J.,Hofsess, Scott,MacIntyre, Euan,Metzger, Joseph,O'Connor, Naphtali,Patel, Kajal,Tong, Xinchun,Tota, Michael R.,Van Der Ploeg, Lex H. T.,Varnerin, Jeff P.,Fisher, Michael H.,Wyvratt, Matthew J.,Weber, Ann E.,Parmee, Emma R.
, p. 3983 - 3987 (2007/10/03)
Aryldihydropyridazinones and aryldimethylpyrazolones with 2-benzyl vinylogous amide substituents have been identified as potent PDE3B subtype selective inhibitors. Dihydropyridazinone 8a (PDE3B IC50=0.19 nM, 3A IC50=1.3 nM) was selec
